Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Abatacept therapeutic use"" wg kryterium: Temat


Wyświetlanie 1-6 z 6
Tytuł :
Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion?:An analysis of the AMPLE and ATTEST trials
Autorzy :
Buch, Maya H
Johnsen, Alyssa
Schiff, Michael
Pokaż więcej
Temat :
skin and connective tissue diseases
Infliximab
DNA/analysis
Antibodies, Monoclonal/therapeutic use
musculoskeletal diseases
Abatacept/therapeutic use
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Antirheumatic Agents/therapeutic use
Arthritis, Rheumatoid/drug therapy
Treatment Failure
immune system diseases
Methotrexate/therapeutic use
stomatognathic diseases
Humans
Źródło :
Buch, M H, Johnsen, A & Schiff, M 2019, ' Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials ', Clinical and Experimental Rheumatology, vol. 37, no. 1, pp. 127-132 .
Tytuł :
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Autorzy :
Dixon, William G
Hyrich, Kimme L
Mercer, Louise K
Askling, Johan
Raaschou, Pauline
Dreyer, Lene
Hetland, Merete Lund
Strangfeld, Anja
Zink, Angela
Mariette, Xavier
Finckh, Axel
Canhao, Helena
Iannone, Florenzo
Zavada, Jakub
Morel, Jacques
Gottenberg, Jacques-Eric
Listing, Joachim
Pokaż więcej
Temat :
Registries
Clinical and Epidemiological Research
Skin Neoplasms
Antibodies, Monoclonal, Humanized
Anti-TNF
Biological Products
Rituximab/therapeutic use
Tumor Necrosis Factor-alpha
Epidemiology
Antirheumatic Agents/therapeutic use
Arthritis, Rheumatoid/drug therapy
Antirheumatic Agents
Skin Neoplasms/epidemiology
Female
Europe
Rituximab
Risk Factors
Biological Products/therapeutic use
ddc:616
Abatacept
Aged
Melanoma
Middle Aged
Rheumatoid Arthritis
Melanoma/epidemiology
Abatacept/therapeutic use
Tumor Necrosis Factor-alpha/antagonists & inhibitors
Arthritis, Rheumatoid
Antibodies, Monoclonal, Humanized/therapeutic use
Europe/epidemiology
Journal Article
Adult
Aged, 80 and over
Humans
Incidence
Male
Źródło :
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, Vol. 76, No 2 (2017) pp. 386-391
Mercer, L K, Askling, J, Raaschou, P, Dixon, W G, Dreyer, L, Hetland, M L, Strangfeld, A, Zink, A, Mariette, X, Finckh, A, Canhao, H, Iannone, F, Zavada, J, Morel, J, Gottenberg, J-E, Hyrich, K L & Listing, J 2017, ' Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics : results from a collaborative project of 11 European biologic registers ', Annals of the Rheumatic Diseases, vol. 76, no. 2, pp. 386-391 . https://doi.org/10.1136/annrheumdis-2016-209285
Mercer, L, Askling, J, Raaschou, P, Dixon, W, Dreyer, L, Lund Hetland, M, Strangfeld, A, Zink, A, Mariette, X, Finckh, A, Canhao, H, Iannone, F, Zavada, J, Morel, J, Gottenberg, J-E, Hyrich, K & Listing, J 2016, ' Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers ', Annals of the rheumatic diseases . https://doi.org/10.1136/annrheumdis-2016-209285
Opis pliku :
application/pdf
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies